glucagon has been researched along with apomorphine in 3 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (apomorphine) | Trials (apomorphine) | Recent Studies (post-2010) (apomorphine) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 9,205 | 287 | 780 |
| Protein | Taxonomy | glucagon (IC50) | apomorphine (IC50) |
|---|---|---|---|
| Tryptophan 5-hydroxylase 1 | Rattus norvegicus (Norway rat) | 0.22 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0146 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D | Rattus norvegicus (Norway rat) | 0.4744 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| D(2) dopamine receptor | Bos taurus (cattle) | 0.3385 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.025 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.025 | |
| D(1B) dopamine receptor | Homo sapiens (human) | 0.025 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.025 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0813 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.205 | |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 1.35 | |
| D | Bos taurus (cattle) | 0.3385 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohannon, NV; Forsham, PH; Gerich, JE; Karam, JH; Lorenzi, M; Tsalikian, E | 1 |
| Arnerić, SP; Bhatnagar, RK; Chow, SA; Fischer, LJ; Long, JP; Webb, RL | 1 |
| Forsham, PH; Karam, JH; Lorenzi, M; McIlroy, MB | 1 |
3 other study(ies) available for glucagon and apomorphine
| Article | Year |
|---|---|
Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
Topics: Adult; Apomorphine; Blood Glucose; Diabetes Mellitus, Type 1; Female; Glucagon; Growth Hormone; Humans; Insulin; Levodopa; Male; Prolactin; Receptors, Dopamine | 1977 |
Evidence that central dopamine receptors modulate sympathetic neuronal activity to the adrenal medulla to alter glucoregulatory mechanisms.
Topics: Adrenal Medulla; Animals; Apomorphine; Catecholamines; Glucagon; Glucose; Glycogen; Homeostasis; Hypothalamus; Insulin; Male; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sympathetic Nervous System | 1984 |
Increased growth hormone response to dopamine infusion in insulin-dependent diabetic subjects: indication of possible blood-brain barrier abnormality.
Topics: Adult; Apomorphine; Blood-Brain Barrier; Capillary Permeability; Diabetes Mellitus, Type 1; Dopamine; Female; Glucagon; Growth Hormone; Humans; Infusions, Parenteral; Insulin; Physical Exertion | 1980 |